DEUTSCHE BANK AG\ - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 26 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,000
-97.8%
1,200
-89.4%
0.00%
Q3 2016$91,000
+15.2%
11,287
-34.6%
0.00%
Q2 2016$79,000
+2533.3%
17,263
+2245.5%
0.00%
Q1 2016$3,000
-66.7%
736
-40.6%
0.00%
Q4 2015$9,000
-50.0%
1,239
-10.7%
0.00%
Q3 2015$18,000
+80.0%
1,388
+105.6%
0.00%
Q2 2015$10,0006750.00%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 1,195,013$9,249,0001.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$28,889,0001.17%
TIGER MANAGEMENT L.L.C. 650,915$5,038,0000.65%
RA Capital Management 612,863$4,744,0000.47%
WALL STREET ASSOCIATES 170,400$1,319,0000.37%
Rock Springs Capital Management LP 489,000$3,785,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 231,548$1,792,0000.26%
SABBY MANAGEMENT, LLC 503,595$3,898,0000.21%
KINGDON CAPITAL MANAGEMENT, L.L.C. 399,663$3,093,0000.15%
DAFNA Capital Management LLC 15,000$116,0000.10%
View complete list of NIVALIS THERAPEUTICS INC shareholders